Semax -10mg

Semax is a synthetic seven-amino-acid peptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). It is an analogue of the ACTH(4–10) peptide fragment and has been investigated extensively in experimental neuroscience and peptide pharmacology. The 10 mg presentation is intended for qualified research environments conducting controlled investigations into peptide structure, neurobiological signaling, neurotrophic pathways, cellular responses, and related preclinical research.

Key Features

10 mg research-grade Semax Synthetic heptapeptide Semax / ACTH(4–10) analogue MEHFPGP peptide sequence Relevant to neurobiology and peptide pharmacology research Suitable for neurotrophic signaling studies Intended for controlled in-vitro and preclinical research Appropriate for peptide characterization and analytical workflows Batch-level analytical documentation may be provided for applicable lots Research Focus Semax has been investigated in experimental models for its relationship with BDNF and TrkB signaling. Research has reported changes in BDNF expression and TrkB activation following exposure to Semax, providing a basis for continued investigation into its molecular and cellular mechanisms. Additional laboratory research has examined Semax in relation to neurotrophin gene expression and other neurobiological signaling pathways. Much of the available mechanistic evidence comes from animal and cellular research models.

Important Notice

This product is supplied strictly for research and laboratory use. It is not intended for human or veterinary use, self-administration, consumption, cognitive enhancement, diagnosis, treatment, or prevention of disease. This research material should be handled only by appropriately qualified personnel in accordance with applicable laboratory protocols, analytical requirements, and regulations.